Patients Must Be Told To Undertake Lifelong Art. Start Treatment For Symptomatic Patients Regardless Of Cd4 Cell Count. Start Drugs For Asymptomatic Individuals With Cd4 Cell Counts <500/l. Do Risk Reduction Counseling At Each Patient–clinician Interaction. Regimen: Consider Resistance–testing Results And Predicted Virologic Efficacy, Toxicity And Tolerability, Pill Burden, Dosing Frequency, Drug–drug Interactions, Comorbidities, Patient And Practitioner Preference, And Cost And Affordability. Combine Two Nucleoside Reverse Transcriptase Inhibitors And A Potent Third Agent From Another Class. Prefer A Fixed–dose Formulations And Once–daily Regimen. Suppress Hiv To Less Than 50 Copies/ml (polymerase Chain Reaction) Or 75 Copies/μl (branched Dna) By 24 Weeks. To Detect Failure: Repeat Testing Of Hiv–1 Rna 2 To 8 Weeks After Initiation, Every Four To Eight Weeks Until Suppressed, And Then Every 3 To 4 Months For At Least The First Year. Monitor Cd4 Cell Counts At Least Every 3 To 4 Months After Starting Therapy, Especially In Patients With Counts <200/μl, To Assess Whether Prophylaxis Is Needed For Opportunistic Infections. Do More Frequent Monitoring In Patients Who Have Changed Therapy Because Of Virologic Failure. Even If One Or More Regimens Have Failed, The Therapeutic Goal Should Still Be Undetectable Plasma Hiv–1 Rna Levels. Achieve This Goal With New Drugs And Regimens. If An Elevation In Viral Load Occurs After Complete Suppression Is Achieved, Consider Poor Adherence, Drug–drug Interactions, Concurrent Infections And Recent Vaccinations As Possible Causes Before Changing Regimens. Repeat Testing For An Isolated Detectable Viral Load To Exclude Errors Or Self–resolving Low–level Viremia. When Changing Regimens After First– Or Multiple–regimen Failure, Consider The Stage Of Hiv, Nadir And Current Cd4 Cell Count, Comorbidities, Treatment History, Current And Previous Drug Resistance Tests, And Drug Interactions. Include At Least Two Drugs, And Preferably Three Fully Active Drugs Or Drugs From New Classes. Single–agent Switches To Decrease Toxicity, Avoid Drug Interactions, Or Improve Convenience And Adherence Are Possible, Provided The Potency Of The Regimen Is Maintained And Drug Interactions Are Managed. Boosted Protease Inhibitor Monotherapy Is Not Recommended, Except When Other Drugs Raise Issues Of Toxicity Or Tolerability. Delaying Such Switches May Affect Adherence And Risk Development Of Resistance

Intensive Practical Training Program In Psychological Counselling The Heart To Heart Counselling Centre Has Organised A Six-week Intensive Practical Training Program In Psychological Counselling Along With Sensitivity Training During February-march-april 2012 At Heart To Heart Counselling Centre, 10 Jerbai Baug, Ambedkar Road, Near Gloria Chuch, Byculla (east), Mumbai 27, India. This Course Is An Intensive Professional Level Certificate Course In Counselling Based On Robert Carkhuff Model Of Counselling - An Offshoot Of Carl Roger’s Client Centered Therapy. This Professional Training Is Rooted In Humanistic Psychotherapy Where You Learn The Scientific, Contemporary And Internationally Most Widely Accepted Methodology Of Counselling By An International Trainer Dr.minnu R. Bhonsle. It Is Ideal For Those Who Are Or Want To Be In People-oriented Professions Such As Psychologists, Counsellors, Hr Personnel, Leaders & Trainers In Corporate World, Teachers, Social Workers, Doctors, Therapists, Healers, Yoga Teachers, Medical, Paramedical & Psychology Students, Management Trainees And Social Workers. Venue: Heart To Heart Counselling Centre, 10 Jerbai Baug, Ambedkar Road, Near Gloria Chuch, Byculla (east), Mumbai 400027, India Duration: Six Weeks. Total 20 Sessions Of Two Hours Each On Mondays, Wednesdays And Fridays. Timings: Morning Batch (11.15 A.m. To 1.15 P.m.), Afternoon Batch (2.45 To 4.45 P.m.) & Evening Batch (5.45 To 7.45 P.m.) The Prospectus Of The Course Can Be Read On-line By Clicking On Any Of The Following Hyperlink ~ Http://www.hearttoheartindia.net/courses/certificate-course-in-counselling/ Admissions For These Three Batches Are Now Open. Interested Candidates Can Contact On The Following Address & Telephone Numbers For Registration. Prof. Dr. Rajan Bhonsle, M.d.(bom) (hon.professor & Head Of The Department Kem Hospital & G.s. Medical College, Mumbai) Director, Heart To Heart Counselling Centre 10 Jerbai Baug, Ambedkar Road, Near Gloria Church, Byculla (east), Mumbai 400027, India Mobile: 9821093902 Tel : 22184528 / 23778624 / 23755866 Website: Www.hearttoheartindia.net

International Seminar On 'glomerular Diseases' Being Organized At Muljibhai Patel Urological Hospital, Nadiad, On 19-20 August 2011 Kidney Diseases Have Attained Epidemic Proportion All Over The World. End Stage Renal (kidney) Disease (esrd) Affects As Much As 1.8% Of Our Population And About 17% Are At A Risk Of Developing Kidney Diseases. Treatment Of Esrd Is Beyond The Means Of Common Man Even In Advanced Rich Countries. Glomerular Disease Contributes To 25% Of Esrd Patients. These Are Treatable Diseases And Can Be Prevented In Several Situations. Prof. John Feehally, President, International Society Of Nephrology, Will Be The Main Speaker In This Two Day Seminar. Several Reputed Teachers In Nephrology From All Across India Will Also Be Deliberating As A Faculty. The Seminar Will Be Attended By 150 Nephrology Professionals Consisting Of Nephrologists And Postgraduate Students In Nephrology. This Seminar Is Expected To Give A Boost In Understanding Of Glomerular Disease, It's Treatment And Cutting Edge Research In This Field In Our Country. Joseph@mpuh.org